ID   KKK-D138
AC   CVCL_XD20
SY   KKK-D131H2
DR   JCRB; JCRB1779
DR   Wikidata; Q94340052
RX   PubMed=31077409;
RX   PubMed=31126020;
RX   PubMed=35640676;
CC   Population: Southeast Asian; Thai.
CC   Characteristics: Established from a second generation xenograft established in BALB/c Rag-2-/-/Jak3-/- mice.
CC   Derived from site: In situ; Bile duct; UBERON=UBERON_0002394.
ST   Source(s): JCRB=JCRB1779; PubMed=31126020
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11
ST   D16S539: 9,11
ST   D18S51: 15
ST   D19S433: 13.2,14.2
ST   D21S11: 29
ST   D2S1338: 24,25
ST   D3S1358: 16,18
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   D8S1179: 10,14
ST   FGA: 18,24.2
ST   TH01: 8,9.3
ST   TPOX: 11
ST   vWA: 14,18
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 02-05-24; Version: 8
//
RX   PubMed=31126020; DOI=10.3390/cells8050496; PMCID=PMC6562875;
RA   Vaeteewoottacharn, Kulthida
RA   Pairojkul, Chawalit
RA   Kariya, Ryusho
RA   Muisuk, Kanha
RA   Imtawil, Kanokwan
RA   Chamgramol, Yaovalux
RA   Bhudhisawasdi, Vajarabhongsa
RA   Khuntikeo, Narong
RA   Pugkhem, Ake
RA   Saeseow, O-Tur
RA   Silsirivanit, Atit
RA   Wongkham, Chaisiri
RA   Wongkham, Sopit
RA   Okada, Seiji
RT   "Establishment of highly transplantable cholangiocarcinoma cell lines
RT   from a patient-derived xenograft mouse model.";
RL   Cells 8:496.1-496.15(2019).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155;
RA   Isidan, Abdulkadir
RA   Yenigun, Ali
RA   Soma, Daiki
RA   Aksu, Eric
RA   Lopez, Kevin
RA   Park, Yujin
RA   Cross-Najafi, Arthur
RA   Li, Ping
RA   Kundu, Debjyoti
RA   House, Michael G.
RA   Chakraborty, Sanjukta
RA   Glaser, Shannon
RA   Kennedy, Lindsey
RA   Francis, Heather
RA   Zhang, Wen-Jun
RA   Alpini, Gianfranco D.
RA   Ekser, Burcin
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//
RX   PubMed=31077409; DOI=10.1002/hep.30704;
RA   Sittithumcharee, Gunya
RA   Suppramote, Orawan
RA   Vaeteewoottacharn, Kulthida
RA   Sirisuksakun, Chumphon
RA   Jamnongsong, Supawan
RA   Laphanuwat, Phatthamon
RA   Suntiparpluacha, Monthira
RA   Matha, Arriya
RA   Chusorn, Porncheera
RA   Buraphat, Pongsakorn
RA   Kakanaporn, Chumpot
RA   Charngkaew, Komgrid
RA   Silsirivanit, Atit
RA   Korphaisarn, Krittiya
RA   Limsrichamrern, Somchai
RA   Tripatara, Pinpat
RA   Pairojkul, Chawalit
RA   Wongkham, Sopit
RA   Sampattavanich, Somponnat
RA   Okada, Seiji
RA   Jirawatnotai, Siwanon
RT   "Dependency of cholangiocarcinoma on cyclin D-dependent kinase
RT   activity.";
RL   Hepatology 70:1614-1630(2019).
//